Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2008
11/05/2008CN101297792A Injection for curing retained afterbirth of beast and preparation thereof
11/05/2008CN101297791A Alprostadil composition and preparation thereof
11/05/2008CN101297790A Zaltoprofen sustained-release preparation and preparation thereof
11/05/2008CN101297669A Chitosan oral scented pieces and preparation thereof
11/05/2008CN100430093C Temperature responsive delivery systems
11/05/2008CN100430092C Lipid composition for providing genes and polypeptides with medicines by mucosa and its preparation
11/05/2008CN100430087C Chinese traditional medicine prescription for treating hepatitis B and preparation technics
11/05/2008CN100430085C Medicine for ventilating the lung and resolving phlegm to relieve cough and preparing method
11/05/2008CN100430083C Menstruation regulating and spot eliminating bolus and its prepn
11/05/2008CN100430082C Glossy ganoderma spore essential oil compound capsules and preparation thereof
11/05/2008CN100430076C Medicine composition for treating hyperlipemia and coronary disease and preparation method thereof
11/05/2008CN100430073C Use of compound red-rooted salvia drop pills in preparation of leucocyte adherence prohibiting drug
11/05/2008CN100430070C Medication for treating coronary heart disease and angina
11/05/2008CN100430069C Reversible heat gelling aquatic pharmaceutical composition of a Chinese medicine and compound prescription thereof
11/05/2008CN100430067C Carboxylate-gated-nitroxide (CGN) compounds and compositions and methods of use thereof
11/05/2008CN100430055C Glassiness sosoloid contg. 2-(3-cyano-4-isobutoxyphenyl)-4-methyl-5-thiazol formic-acid and polyvinyl pyrrolidone and its prepn. method
11/05/2008CN100430053C AIDS therapeutic drug and its uses
11/05/2008CN100430051C Pharmaceutical formulation comprising levothyroxine sodium
11/05/2008CN100430047C Chinese medicine composition for peridentitis and preparing method thereof
11/05/2008CN100430046C Composition and method for treating age-related disorders
11/05/2008CN100430045C Radix bupleuri dripping pill and its preparing method
11/05/2008CN100430044C Nail restructuring compositions for topical application
11/05/2008CN100429997C Alcohol-relieving tablet containing kudzu root and spirulina spp. ,and its preparation method
11/04/2008US7445797 Increasing the thermal conductivity of polymers, fillers, electronic materials
11/04/2008US7445796 Screening the particles using ultrasonic energy to cause agglomerates of smaller particles held together by electrostatic attraction to become deagglomerated
11/04/2008US7445795 Delivery device, method of using and method of manufacturing
11/04/2008US7445793 Support for tissue regeneration and process for producing the same
11/04/2008US7445789 2-(methacryloyloxy)ethyl 2-(acetyloxy)-4-(trifluoromethyl)benzoate; coating for synthetic biomaterials; for prostheses and other devices that are in contact with blood during use
11/04/2008US7445787 Veterinary medicine; brain disorders; immunizing with vaccine comprising West Nile virus or plasmid DNA, an adjuvant such as a metabolizable oil carrier
11/04/2008US7445770 Use in cosmetic applications such as hair fixatives; less or no flaking, provides improved humidity retention, higher luster and natural feel, excellent adhesion to hair
11/04/2008US7445769 Compositions for removing stains from dental surfaces and methods of making and using the same
11/04/2008US7445768 Delivery of sedative-hypnotics through an inhalation route
11/04/2008US7445766 Miniaturized device; substrate with reservoirs, openings; barriers layer covering aperture
11/04/2008US7445616 Temperature responsive systems
11/04/2008CA2578881C Vitamin d compositions and method of administration to a human being
11/04/2008CA2457361C Opioid agonist formulations with releasable and sequestered antagonist
11/04/2008CA2441860C Systems for delivering a cosmetic and/or therapeutic active to oral surfaces
11/04/2008CA2362481C Echinocandin pharmaceutical formulations containing micelle-forming surfactants
11/04/2008CA2324260C Sulfurpenta fluorophenyl pyrazoles for controlling ectoparasitic infestations
11/04/2008CA2282893C Heat stable antacid and antigas suspensions
11/04/2008CA2197432C Liquid immunoglobulin formulations
11/04/2008CA2169834C Pharmaceutical formulations of nerve growth factor
11/02/2008CA2591516A1 An autonomous method for oral delivery of a healing substance to a target place in gastrointestinal tract of humans or animals
11/02/2008CA2587064A1 Antimicrobial gel for skin
10/2008
10/30/2008WO2008131340A1 Orally disintegrating tablet comprising glycopyrrolate for treating sialorrhea
10/30/2008WO2008131260A1 Derivatives of amyris alcohols and eudesmol for treating cold sores and herpes
10/30/2008WO2008131217A1 Ultrasound imaging with targeted microbubbles
10/30/2008WO2008131170A1 Aerosol dispersions of particles with active pharmaceutical ingredients
10/30/2008WO2008131129A2 Nucleic acid microparticles for pulmonary delivery
10/30/2008WO2008131070A1 Method for supplying oxygenated water to promote internal healing
10/30/2008WO2008131057A2 Sustained release formulations of opioid and nonopioid analgesics
10/30/2008WO2008131056A2 Sustained release monoeximic formulations of opioid and nonopioid analgesics
10/30/2008WO2008130883A1 Embedded liquid lubricants for tableting
10/30/2008WO2008130803A2 Pulmonary delivery of spherical insulin microparticles
10/30/2008WO2008130641A1 Drug delivery vehicle containing vesicles in a hydrogel base
10/30/2008WO2008130624A1 Protein-modified nano-droplets, compositions and methods of production
10/30/2008WO2008130587A2 Solvent-cast microneedle arrays containing active
10/30/2008WO2008130234A1 High dose composition of ursodeoxycholic acid
10/30/2008WO2008130180A1 Preparation of drug delivery systems using ph-sensitive block copolymer and their application
10/30/2008WO2008130158A1 A biodegradable microsphere composition suitable for the controlled release of glucose controlling peptide and formulation thereof
10/30/2008WO2008130137A1 Anionic lipid nanosphere and preparation method of the same
10/30/2008WO2008129980A1 Particulate composition comprising reduced coenzyme q10, and method for production thereof
10/30/2008WO2008129937A1 Multilayer structure for oral applications and method for production thereof
10/30/2008WO2008129846A1 Pharmaceutical composition
10/30/2008WO2008129730A1 Process for producing preparation for oral administration
10/30/2008WO2008129517A2 A stabilized delayed release pharmaceutical composition of rabeprazole
10/30/2008WO2008129507A1 Controlled release multiple layer coatings
10/30/2008WO2008129501A2 Pharmaceutical compositions of duloxetine
10/30/2008WO2008129318A2 A foam material for medical use and method for producing same
10/30/2008WO2008129303A2 Sustained release
10/30/2008WO2008129270A2 Compositions comprising anti-inflammatory compounds
10/30/2008WO2008129106A2 Nanoparticles comprising a cyclodextrin and a biologically active molecule and uses thereof
10/30/2008WO2008129043A1 Combination with an extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof
10/30/2008WO2008128992A1 Cores and microcapsules suitable for parenteral administration as well as process for their manufacture
10/30/2008WO2008128960A1 Process for dosing self-emulsifying drug delivery systems
10/30/2008WO2008128924A1 Preparation for the controlled release of bioactive natural substances
10/30/2008WO2008128779A1 Ophthalmic oil-in-water emulsions containing prostaglandins
10/30/2008WO2008128580A1 Microspheres for treatment of brain tumours
10/30/2008WO2008128342A1 Composition for enhancing bone formation
10/30/2008WO2008128292A1 Nanoparticle-coated capsule formulation for dermal drug delivery
10/30/2008WO2008109427A3 Anesthetic spray composition
10/30/2008WO2008100534A3 Biomimetic nanofiber scaffold for soft tissue and soft tissue-to-bone repair, augmentation and replacement
10/30/2008WO2008100142A3 Vaccine formulation
10/30/2008WO2008089260A3 Combined administration of benzonatate and guaifenesin
10/30/2008WO2008087605B1 Composition and method of stabilized sensitive ingredient
10/30/2008WO2008087323A3 Galenic form for the transmucosal delivery of paracetamol
10/30/2008WO2008084237A3 Stabilization of aqueous compositions of proteins with displacement buffers
10/30/2008WO2008075206A3 Cell-matrix microspheres, methods for preparation and applications
10/30/2008WO2008069921A3 Oral transmucosal nicotine dosage form
10/30/2008WO2008064202A3 Modified-release formulations of calcium receptor-active compounds
10/30/2008WO2008063158A3 Method for nanoencapsulation
10/30/2008WO2008052126A3 Ointment comprising phosphatidylserine as active agent for cancer treatment
10/30/2008WO2008049657A3 Use of (meth)acrylate copolymers in slow-release pharmaceutical forms for reducing the influence of ethanol on active ingredient release
10/30/2008WO2008034122A3 Hindered ester-based biodegradable linkers for oligonucleotide delivery
10/30/2008WO2008033487A3 Method for preparing solid dosage forms that form a paste, cream or gel when diluted for final use
10/30/2008WO2008027557A3 Topiramate compositions and methods of enhancing its bioavailability
10/30/2008WO2008027341A3 Topical ophthalmic formulations
10/30/2008WO2008024426A3 Nanosilver-containing absorbent articles
10/30/2008WO2008021210A3 Methods and compositions for the treatment of neurodegenerative disorders
10/30/2008WO2008016490A3 Modified two-component gelation systems for the treatment of post-myocardial infarction
1 ... 1159 1160 1161 1162 1163 1164 1165 1166 1167 1168 1169 1170 1171 1172 1173 1174 1175 1176 1177 1178 1179 ... 2991